Lesley Ashdown-Barr

1.1k total citations
13 papers, 816 citations indexed

About

Lesley Ashdown-Barr is a scholar working on Epidemiology, Oncology and Surgery. According to data from OpenAlex, Lesley Ashdown-Barr has authored 13 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in Lesley Ashdown-Barr's work include Cervical Cancer and HPV Research (12 papers), Global Cancer Incidence and Screening (5 papers) and Genital Health and Disease (3 papers). Lesley Ashdown-Barr is often cited by papers focused on Cervical Cancer and HPV Research (12 papers), Global Cancer Incidence and Screening (5 papers) and Genital Health and Disease (3 papers). Lesley Ashdown-Barr collaborates with scholars based in United Kingdom and United States. Lesley Ashdown-Barr's co-authors include Louise Cadman, Anne Szarewski, Jo Waller, Janet Austin, Jack Cuzick, David Mesher, George Terry, Linda Ho, D. Lyons and Stuart Liddle and has published in prestigious journals such as Journal of Clinical Microbiology, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

Lesley Ashdown-Barr

13 papers receiving 801 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lesley Ashdown-Barr United Kingdom 12 741 294 208 190 169 13 816
Eileen Dareng United States 16 498 0.7× 178 0.6× 132 0.6× 161 0.8× 154 0.9× 30 685
Ameli Tropé Norway 14 443 0.6× 166 0.6× 61 0.3× 147 0.8× 85 0.5× 30 518
Crispin Kahesa United States 14 440 0.6× 239 0.8× 65 0.3× 136 0.7× 115 0.7× 40 569
Sara Smith United States 8 533 0.7× 319 1.1× 77 0.4× 95 0.5× 101 0.6× 14 656
Gry Baadstrand Skare Norway 16 718 1.0× 327 1.1× 78 0.4× 219 1.2× 103 0.6× 28 824
M. Desai United Kingdom 12 1.0k 1.4× 307 1.0× 111 0.5× 483 2.5× 165 1.0× 22 1.1k
Esther Roura Spain 9 461 0.6× 250 0.9× 38 0.2× 168 0.9× 50 0.3× 19 575
Bengt Andrae Sweden 15 956 1.3× 515 1.8× 97 0.5× 202 1.1× 111 0.7× 28 1.1k
Matthys H. Botha South Africa 16 354 0.5× 191 0.6× 98 0.5× 144 0.8× 90 0.5× 59 632
Kai-Li Liaw United States 15 567 0.8× 79 0.3× 54 0.3× 318 1.7× 128 0.8× 20 704

Countries citing papers authored by Lesley Ashdown-Barr

Since Specialization
Citations

This map shows the geographic impact of Lesley Ashdown-Barr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lesley Ashdown-Barr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lesley Ashdown-Barr more than expected).

Fields of papers citing papers by Lesley Ashdown-Barr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lesley Ashdown-Barr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lesley Ashdown-Barr. The network helps show where Lesley Ashdown-Barr may publish in the future.

Co-authorship network of co-authors of Lesley Ashdown-Barr

This figure shows the co-authorship network connecting the top 25 collaborators of Lesley Ashdown-Barr. A scholar is included among the top collaborators of Lesley Ashdown-Barr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lesley Ashdown-Barr. Lesley Ashdown-Barr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Cadman, Louise, Caroline Reuter, Mark Jitlal, et al.. (2021). A Randomized Comparison of Different Vaginal Self-sampling Devices and Urine for Human Papillomavirus Testing—Predictors 5.1. Cancer Epidemiology Biomarkers & Prevention. 30(4). 661–668. 49 indexed citations
2.
Louie, Karly S., Caroline Reuter, Sara L. Bissett, et al.. (2018). Evaluation of Dried Blood Spots and Oral Fluids as Alternatives to Serum for Human Papillomavirus Antibody Surveillance. mSphere. 3(3). 7 indexed citations
3.
Cuzick, Jack, Amar Ahmad, Janet Austin, et al.. (2016). A comparison of different human papillomavirus tests in PreservCyt versus SurePath in a referral population—PREDICTORS 4. Journal of Clinical Virology. 82. 145–151. 14 indexed citations
4.
Cuzick, Jack, Kate Cuschieri, Karin Denton, et al.. (2015). Performance of the Xpert HPV assay in women attending for cervical screening. Papillomavirus Research. 1. 32–37. 25 indexed citations
5.
Cuzick, Jack, Linda Ho, George Terry, et al.. (2014). Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions. Journal of Clinical Virology. 60(1). 44–49. 45 indexed citations
6.
Cadman, Louise, Scott Wilkes, Diana Mansour, et al.. (2014). A randomized controlled trial in non-responders from Newcastle upon Tyne invited to return a self-sample for Human Papillomavirus testing versus repeat invitation for cervical screening. Journal of Medical Screening. 22(1). 28–37. 42 indexed citations
7.
Cadman, Louise, Lesley Ashdown-Barr, Jo Waller, & Anne Szarewski. (2014). Attitudes towards cytology and human papillomavirus self-sample collection for cervical screening among Hindu women in London, UK: a mixed methods study. Journal of Family Planning and Reproductive Health Care. 41(1). 38–47. 29 indexed citations
8.
Cuzick, Jack, Louise Cadman, David Mesher, et al.. (2013). Comparing the performance of six human papillomavirus tests in a screening population. British Journal of Cancer. 108(4). 908–913. 160 indexed citations
9.
Mesher, David, Anne Szarewski, Louise Cadman, et al.. (2013). Comparison of human papillomavirus testing strategies for triage of women referred with low-grade cytological abnormalities. European Journal of Cancer. 49(9). 2179–2186. 28 indexed citations
10.
Szarewski, Anne, David Mesher, Louise Cadman, et al.. (2012). Comparison of Seven Tests for High-Grade Cervical Intraepithelial Neoplasia in Women with Abnormal Smears: the Predictors 2 Study. Journal of Clinical Microbiology. 50(6). 1867–1873. 130 indexed citations
11.
Cadman, Louise, Jo Waller, Lesley Ashdown-Barr, & Anne Szarewski. (2012). Barriers to cervical screening in women who have experienced sexual abuse: an exploratory study: Table 1. Journal of Family Planning and Reproductive Health Care. 38(4). 214–220. 80 indexed citations
12.
Szarewski, Anne, Louise Cadman, David Mesher, et al.. (2011). HPV self-sampling as an alternative strategy in non-attenders for cervical screening – a randomised controlled trial. British Journal of Cancer. 104(6). 915–920. 130 indexed citations
13.
Szarewski, Anne, Louise Cadman, Lesley Ashdown-Barr, & Jo Waller. (2009). Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the cervical screening context: a qualitative study of Muslim women in London. Journal of Medical Screening. 16(4). 193–198. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026